Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

Authors

Institutions

Publication Details

Journal
The Lancet Infectious Diseases
Published
2025-12-01
DOI
https://doi.org/10.1016/s1473-3099(25)00681-4
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

Federico Pulido, Andrew Ustianowski, Adrián Curran, Georg M. N. Behrens et al.
The Lancet Infectious Diseases
HIV/AIDS drug development and treatment
article

Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial

Federico Pulido, Andrew Ustianowski, Adrián Curran, Georg M. N. Behrens, Lisa Hamzah, Christine Katlama, Geoffroy Liégeon, Brenda Crabtree, Jack Moody, Pere Domingo, Julie Fox, Andrea Antinori, Hernando Knobel, Phil Bright, Nikos Dedes, Christoph D. Spinner, Jean‐Michel Molina, Anton Pozniak, Francesco Genderini, Joaquín Portilla, Jürgen K. Rockstroh, Gema Jiménez, Chris Kenyon, Aoife G. Cotter, Frank A. Post, Karine Lacombe, Estebán Martínez, Janina Trauth, Lambert Assoumou, Roya Movahedi, Robert F. Miller, Alberto Díaz de Santiago, Antonella Castagna, Rafael Micán, Monserrat Laguno, Juan González, François Raffi, Carl Fletcher
article en

Abstract

No abstract available for this paper.
The Lancet Infectious Diseases
Inserm (FR), Université Paris Cité (FR), University Hospital Bonn (DE), Hospital Universitario La Paz (ES), Hospital de Sant Pau (ES), Medizinische Hochschule Hannover (DE), Sorbonne Université (FR), Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT), King's College Hospital NHS Foundation Trust (GB), St George's Hospital (GB), Hospital Clínic de Barcelona (ES), Hôpital Lariboisière (FR), Vall d'Hebron Hospital Universitari (ES), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Chelsea and Westminster Hospital (GB), Centre for Individualised Infection Medicine (DE), Centre Hospitalier Universitaire de Saint-Pierre (BE)
Gilead Sciences, Janssen Pharmaceuticals
Openalex Percentile: Top 56%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.